Dihydroergotamine in an orally inhaled form has completed Phase III trials. The novel delivery system consists of an inhaler (TEMPO®; MAP Pharmaceuticals), which uses a breath-triggered ...
These free online tools let you skip the setup and start tracking your money right away. Many, or all, of the products featured on this page are from our advertising partners who compensate us ...
Following the advent of the triptans, the use of dihydroergotamine (DHE) declined, because of the ease of use and improved side effect profiles of triptans. However, there remain many patients who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results